Abstract:Abstract Background As we all know, patients with epithelial ovarian carcinoma have poor prognosis and high recurrence rate. It is critical and challenging to screen out the patients with high risk of recurrence. At present, there are some models predicting the overall survival of epithelial ovarian carcinoma, however, there is no widely accepted tool or applicable model predicting the recurrence risk of epithelial ovarian carcinoma patients. The objective of this study was to establish and verify a nomogram to predict the recurrence risk of EOC. Methods We reviewed the clinicopathological and prognostic data of 193 patients with EOC who achieved clinical complete remission after cytoreductive surgery and chemotherapy between January 2003 and December 2013 in Peking University First Hospital. The nomogram was established with the risk factors selected by LASSO regression. The medical data of 187 EOC patients with 5-year standard follow-up in Peking University Third Hospital and Beijing Obstetrics and Gynecology Hospital were used for external validation of the nomogram. AUC curve and Hosmer-Lemeshow test were used to evaluate the discrimination and calibration. Results The nomogram for 3-year recurrence risk was established with FIGO stage, histological grade, histological type, lymph node metastasis status and serum CA125 level at diagnosis. The total score can be obtained by adding the grading values of these factors together. The C statistics was 0.828 [95% CI, 0.764–0.884] and the Chi-square value is 3.6 ( P = 0.731 > 0.05) with the training group. When the threshold value was set at 198, the sensitivity, specificity, positive predictive value, negative predictive value and concordance index were 88.8, 67.0, 71.8, 86.3% and 0.558 respectively. In the external validation, the C statistics was 0.803 [95%CI, 0.738–0.867] and the Chi-square value is 11.04 ( P = 0.135 > 0.05). With the threshold value of 198, the sensitivity, specificity, positive predictive value, negative predictive value and concordance index of the nomogram were 75.7, 77.0, 83.2, 67.9%, and 0.52 respectively. Conclusions We established and validated a nomogram to predict 3-year recurrence risk of patients with EOC who achieved clinical complete remission after cytoreductive surgery and chemotherapy. This nomogram with good discrimination and calibration might be useful for screening out the patients with high risk of recurrence.

A Novel Laparoscopy-Based Model for the Prediction of Optimal Cytoreduction and Prognosis of Epithelial Ovarian Cancer in a Chinese Population.

Predictive Factors for Initial Treatment of Advanced Epithelial Ovarian Cancer

Clinical Outcomes and Prognostic Factors of Patients with Epithelial Ovarian Cancer Subjected to First-Line Treatment: a Retrospective Study of 251 Cases

Development and validation of a circulating tumor DNA-based optimization-prediction model for short-term postoperative recurrence of endometrial cancer

Serology-Based Model for Personalized Epithelial Ovarian Cancer Risk Evaluation.

A Triage Strategy in Advanced Ovarian Cancer Management Based on Multiple Predictive Models for R0 Resection: a Prospective Cohort Study

A Prediction Model for Optimal Primary Debulking Surgery Based on Preoperative Computed Tomography Scans and Clinical Factors in Patients With Advanced Ovarian Cancer: A Multicenter Retrospective Cohort Study

A novel clinical nomogram for predicting cancer-specific survival in patients with non-serous epithelial ovarian cancer: A real-world analysis based on the Surveillance, Epidemiology, and End Results database and external validation in a tertiary center

Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma

[Establishment and validation of a prediction model for early-stage epithelial ovarian cancer based on LASSO regression]

Prognostic risk stratification of low-grade serous ovarian cancer: Model development and validation based on machine learning algorithm.

Construction of a Prediction Model of Cancer-Specific Survival after Ovarian Clear Cell Carcinoma Surgery

A Nomogram Model to Predict Recurrence of Early-Onset Endometrial Cancer after Resection Based on Clinical Parameters and Immunohistochemical Markers: a Multi-Institutional Study

Feasibility and Outcome of Primary Laparoscopic Cytoreductive Surgery for Advanced Epithelial Ovarian Cancer: a Comparison to Laparotomic Surgery in Retrospective Cohorts

Novel scoring system incorporating lipoproteins to predict outcomes of epithelial ovarian cancer patients

Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation

New online dynamic nomograms to predict recurrence-free and overall survival after resection of endometrial cancer: a single-institution retrospective cohort study

Prognostic Analysis and Nomogram Establishment in Patients with Early Esophageal Cancer Receiving Endoscopic Therapy: a Population-Based Study.

Women With Ovarian Cancer and With Fertility Preservation: A Survival Analysis Using the Surveillance, Epidemiology, and End Results Database and Construction of Nomograms to Predict Cancer-Specific Survival

A preoperative nomogram incorporating CT to predict the probability of ovarian clear cell carcinoma

Development of Web-Based Nomograms to Predict Treatment Response and Prognosis of Epithelial Ovarian Cancer